Mutant B-RAF mediates resistance to anoikis via Bad and Bim

K Boisvert-Adamo1, A E Aplin

  • 1Center for Cell Biology and Cancer Research, Albany Medical College, Albany, NY 12208, USA.

Oncogene
|February 5, 2008
PubMed

Insights

Melanoma cells resist anoikis, a form of programmed cell death, through B-RAF-MEK signaling. This pathway impacts Bad and Bim proteins, crucial regulators of apoptosis in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Anoikis is programmed cell death triggered by loss of cell-matrix adhesion, a process tumor cells often evade.
  • Mutant B-RAF oncogene signaling is critical for melanoma progression and survival.
  • The role of Bcl-2 family proteins in B-RAF-mediated melanoma survival and anoikis resistance is not well understood.

Purpose of the Study:

  • To investigate the mechanisms by which B-RAF-MEK signaling confers anoikis resistance in melanoma.
  • To identify key Bcl-2 family proteins regulated by B-RAF-MEK signaling that control anoikis.

Main Methods:

  • Utilized RNA interference and overexpression experiments in melanoma cells.
  • Analyzed B-RAF-MEK signaling effects on phosphorylation and mRNA/protein expression of Bad and Bim.
  • Assessed the role of Bad and Bim in anoikis susceptibility upon B-RAF depletion.

Main Results:

  • B-RAF-MEK signaling protects against anoikis by modulating the proapoptotic proteins Bad and Bim.
  • B-RAF-MEK signaling decreases Bad mRNA expression and regulates its phosphorylation.
  • B-RAF-MEK signaling controls Bim(EL) protein turnover, with increased Bim(EL) inducing apoptosis in suspended cells.

Conclusions:

  • Bad and Bim are key B-RAF-responsive proteins that regulate apoptosis and anoikis in melanoma.
  • Targeting Bad and Bim pathways could offer therapeutic strategies for melanoma treatment.
  • Understanding these mechanisms is vital for developing novel cancer therapies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...